Global Acute Intermittent Porphyria Therapeutics Market Research Report 2023

Report ID: 1897873 | Published Date: Jan 2025 | No. of Page: 69 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Acute Intermittent Porphyria Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 350mg
        1.2.3 313mg
    1.3 Market by Application
        1.3.1 Global Acute Intermittent Porphyria Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Pharmacy
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Acute Intermittent Porphyria Therapeutics Market Perspective (2017-2028)
    2.2 Acute Intermittent Porphyria Therapeutics Growth Trends by Region
        2.2.1 Acute Intermittent Porphyria Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Acute Intermittent Porphyria Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Acute Intermittent Porphyria Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Acute Intermittent Porphyria Therapeutics Market Dynamics
        2.3.1 Acute Intermittent Porphyria Therapeutics Industry Trends
        2.3.2 Acute Intermittent Porphyria Therapeutics Market Drivers
        2.3.3 Acute Intermittent Porphyria Therapeutics Market Challenges
        2.3.4 Acute Intermittent Porphyria Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Acute Intermittent Porphyria Therapeutics Players by Revenue
        3.1.1 Global Top Acute Intermittent Porphyria Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Acute Intermittent Porphyria Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Acute Intermittent Porphyria Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Acute Intermittent Porphyria Therapeutics Revenue
    3.4 Global Acute Intermittent Porphyria Therapeutics Market Concentration Ratio
        3.4.1 Global Acute Intermittent Porphyria Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Acute Intermittent Porphyria Therapeutics Revenue in 2021
    3.5 Acute Intermittent Porphyria Therapeutics Key Players Head office and Area Served
    3.6 Key Players Acute Intermittent Porphyria Therapeutics Product Solution and Service
    3.7 Date of Enter into Acute Intermittent Porphyria Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Intermittent Porphyria Therapeutics Breakdown Data by Type
    4.1 Global Acute Intermittent Porphyria Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Acute Intermittent Porphyria Therapeutics Forecasted Market Size by Type (2023-2028)
5 Acute Intermittent Porphyria Therapeutics Breakdown Data by Application
    5.1 Global Acute Intermittent Porphyria Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Acute Intermittent Porphyria Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Acute Intermittent Porphyria Therapeutics Market Size (2017-2028)
    6.2 North America Acute Intermittent Porphyria Therapeutics Market Size by Country (2017-2022)
    6.3 North America Acute Intermittent Porphyria Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Acute Intermittent Porphyria Therapeutics Market Size (2017-2028)
    7.2 Europe Acute Intermittent Porphyria Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Acute Intermittent Porphyria Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Acute Intermittent Porphyria Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Acute Intermittent Porphyria Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Acute Intermittent Porphyria Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Acute Intermittent Porphyria Therapeutics Market Size (2017-2028)
    9.2 Latin America Acute Intermittent Porphyria Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Acute Intermittent Porphyria Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Acute Intermittent Porphyria Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Acute Intermittent Porphyria Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Acute Intermittent Porphyria Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Detail
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Acute Intermittent Porphyria Therapeutics Introduction
        11.1.4 Abbott Revenue in Acute Intermittent Porphyria Therapeutics Business (2017-2022)
        11.1.5 Abbott Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Acute Intermittent Porphyria Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of 350mg
    Table 3. Key Players of 313mg
    Table 4. Global Acute Intermittent Porphyria Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Acute Intermittent Porphyria Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Acute Intermittent Porphyria Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Acute Intermittent Porphyria Therapeutics Market Share by Region (2017-2022)
    Table 8. Global Acute Intermittent Porphyria Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Acute Intermittent Porphyria Therapeutics Market Share by Region (2023-2028)
    Table 10. Acute Intermittent Porphyria Therapeutics Market Trends
    Table 11. Acute Intermittent Porphyria Therapeutics Market Drivers
    Table 12. Acute Intermittent Porphyria Therapeutics Market Challenges
    Table 13. Acute Intermittent Porphyria Therapeutics Market Restraints
    Table 14. Global Acute Intermittent Porphyria Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Acute Intermittent Porphyria Therapeutics Market Share by Players (2017-2022)
    Table 16. Global Top Acute Intermittent Porphyria Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Intermittent Porphyria Therapeutics as of 2021)
    Table 17. Ranking of Global Top Acute Intermittent Porphyria Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Acute Intermittent Porphyria Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Acute Intermittent Porphyria Therapeutics Product Solution and Service
    Table 21. Date of Enter into Acute Intermittent Porphyria Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Acute Intermittent Porphyria Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Acute Intermittent Porphyria Therapeutics Revenue Market Share by Type (2017-2022)
    Table 25. Global Acute Intermittent Porphyria Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Acute Intermittent Porphyria Therapeutics Revenue Market Share by Type (2023-2028)
    Table 27. Global Acute Intermittent Porphyria Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Acute Intermittent Porphyria Therapeutics Revenue Market Share by Application (2017-2022)
    Table 29. Global Acute Intermittent Porphyria Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Acute Intermittent Porphyria Therapeutics Revenue Market Share by Application (2023-2028)
    Table 31. North America Acute Intermittent Porphyria Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Acute Intermittent Porphyria Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Acute Intermittent Porphyria Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Acute Intermittent Porphyria Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Acute Intermittent Porphyria Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Acute Intermittent Porphyria Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Acute Intermittent Porphyria Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Acute Intermittent Porphyria Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Acute Intermittent Porphyria Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Acute Intermittent Porphyria Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Abbott Company Detail
    Table 42. Abbott Business Overview
    Table 43. Abbott Acute Intermittent Porphyria Therapeutics Product
    Table 44. Abbott Revenue in Acute Intermittent Porphyria Therapeutics Business (2017-2022) & (US$ Million)
    Table 45. Abbott Recent Development
    Table 46. Research Programs/Design for This Report
    Table 47. Key Data Information from Secondary Sources
    Table 48. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Acute Intermittent Porphyria Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. 350mg Features
    Figure 3. 313mg Features
    Figure 4. Global Acute Intermittent Porphyria Therapeutics Market Share by Application in 2021 & 2028
    Figure 5. Hospital Case Studies
    Figure 6. Pharmacy Case Studies
    Figure 7. Acute Intermittent Porphyria Therapeutics Report Years Considered
    Figure 8. Global Acute Intermittent Porphyria Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global Acute Intermittent Porphyria Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Acute Intermittent Porphyria Therapeutics Market Share by Region: 2021 VS 2028
    Figure 11. Global Acute Intermittent Porphyria Therapeutics Market Share by Players in 2021
    Figure 12. Global Top Acute Intermittent Porphyria Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Intermittent Porphyria Therapeutics as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by Acute Intermittent Porphyria Therapeutics Revenue in 2021
    Figure 14. North America Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 15. North America Acute Intermittent Porphyria Therapeutics Market Share by Country (2017-2028)
    Figure 16. United States Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. Canada Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Europe Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Acute Intermittent Porphyria Therapeutics Market Share by Country (2017-2028)
    Figure 20. Germany Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. France Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. U.K. Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Italy Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Russia Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Nordic Countries Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Acute Intermittent Porphyria Therapeutics Market Share by Region (2017-2028)
    Figure 28. China Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Japan Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. South Korea Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Southeast Asia Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. India Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Australia Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Latin America Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Acute Intermittent Porphyria Therapeutics Market Share by Country (2017-2028)
    Figure 36. Mexico Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Brazil Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Middle East & Africa Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Acute Intermittent Porphyria Therapeutics Market Share by Country (2017-2028)
    Figure 40. Turkey Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Saudi Arabia Acute Intermittent Porphyria Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Abbott Revenue Growth Rate in Acute Intermittent Porphyria Therapeutics Business (2017-2022)
    Figure 43. Bottom-up and Top-down Approaches for This Report
    Figure 44. Data Triangulation
    Figure 45. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Frequently Asked Questions
Acute Intermittent Porphyria Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Acute Intermittent Porphyria Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Acute Intermittent Porphyria Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Nelarabine

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More